We examined the roles of Notch signaling in the chondrogenesis of mouse mesencephalic neural crest cells. The present study demonstrated that the activation of Notch signaling or the treatment with fibroblast growth factors (FGFs) promotes the differentiation of proliferative and prehypertrophic chondrocytes expressing collagen type II. Notch activation or FGF2 exposure during the first 24 h in culture was critical for the differentiation of proliferative and prehypertrophic chondrocytes. The expression of SOX9, a transcription activator of collagen type II, was also upregulated by Notch activation or FGF2 treatment. The promotion of proliferative and prehypertrophic chondrocyte differentiation by FGF2 was significantly suppressed by the inhibition of Notch signaling using Notch-1 siRNA. These results suggest that FGFs activate Notch signaling and that this activation promotes the chondrogenic specification of mouse mesencephalic neural crest cells. Furthermore, we investigated the expression patterns of Notch-1, SOX9, and p75, which is a marker of undifferentiated neural crest cells, in the mandibular arch where mesencephalic neural crest cells colonize and undergo chondrogenesis. These in vivo observations, coupled with the results of the present in vitro study, suggest that Notch signaling as well as FGFs is a component of epithelial-mesenchymal interactions that promote the chondrogenic specification of mouse mesencephalic neural crest cells.
Introduction
The neural crest is a transient structure in vertebrate embryos. Neural crest cells arise within the neural tube, migrate ventrally and laterally, and contribute significantly to a wide variety of cell types, including melanocytes, peripheral neurons and their glial cells, smooth muscle cells, and skeletal derivatives (Le Douarin and Kalcheim, 1999; Hall, 1999) . Many, but not all, mesencephalic neural crest cells migrate toward the mandibular arch and undergo chondrogenesis in the arch (Kubota et al., 1996; Le Douarin and Kalcheim, 1999; Cerny et al., 2004) . Chondrogenesis involves the formation of mesenchymal condensations (Hall and Miyake, 2000) , the differentiation of proliferative and prehypertrophic chondrocytes, and the maturation from proliferative and prehypertrophic chondrocytes to hypertrophic chondrocytes (Gilbert, 2003) . Proliferative and prehypertrophic chondrocytes express collagen type II (Nah et al., 1988) . The expression of collagen type II is directly regulated by a transcriptional factor, SOX9, which is a member of the SRY-like HMG box-containing gene family (Bell et al., 1997) . In contrast, hypertrophic chondrocytes do not express collagen type II but do express collagen type X (Schmid and Linsenmayer, 1985; Linsenmayer et al., 1991; Chung et al., 1995) .
It has been shown that fibroblast growth factor (FGF) 2 promotes chondrogenesis and skeletogenesis of quail mesencephalic neural crest cells (Sarkar et al., 2001) and that FGF signaling is a key requisite for cartilage formation in the zebrafish head (Walshe and Mason, 2003) . Furthermore, FGF2 activates Notch signaling in the gliogenesis of mouse neural crest cells (Ota and Ito, 2006) . Notch signaling is an evolutionarily conserved mechanism that influences various biological processes, such as cell fate specification, differentiation, proliferation, and apoptosis (Artavanis-Tsakonas et al., 1999; Miele and Osborne, 1999) . The Notch signaling pathway is activated by the interactions between Notch receptors and their transmembrane ligands, including Delta. In the present study, we focused on the roles of Notch signaling in the chondrogenesis of mouse mesencephalic neural crest cells and investigated the functional relationship between Notch signaling and signaling molecules, such as FGFs and bone morphogenetic proteins (BMPs) which are known to promote chondrogenic differentiation. We demonstrated that the activation of Notch signaling promotes the specification of chondrocytes, but suppresses the maturation to hypertrophic chondrocytes. Thus, Notch signaling may carry out opposite functions in different phases of the chondrogenesis of mouse mesencephalic neural crest cells.
Results

Effects of Notch signaling and signaling molecules on the differentiation of proliferative and prehypertrophic chondrocytes
Mouse mesencephalic neural crest cells were cultured in the presence or absence of a fusion protein containing the extracellular domain of a Notch ligand, Delta-1, and the Fc region of human immunoglobulin IgG (Delta-Fc) or signaling molecules. Whereas a large number of small and polygonal cells appeared in the cultures containing FGFs or Delta-Fc, many flattened cells were observed in the absence of Delta-Fc and signaling molecules or in the presence of BMPs. After 4 days in culture, cell aggregates resembling cartilage nodules particularly appeared in the presence of FGFs or Delta-Fc (Fig. 1D) . However, such cell aggregates were not found in the absence of Delta-Fc and signaling molecules or in the cultures containing BMPs or the Fc region of human immunoglobulin IgG (Fc) only (Fig. 1B) . The cell aggregates increased in size. To examine the effects of Notch signaling and signaling molecules on the chondrogenesis of the neural crest cells, we added Delta-Fc or signaling molecules to the neural crest cell cultures and carried out Alcian Blue staining. Alcian Blue-positive cell population was observed in all culture conditions examined. However, the number of neural crest cell colonies (each colony was derived from a primary explant) containing Alcian Blue-positive cells differed among the culture conditions. Whereas only a half of the colonies examined (7/13) contained Alcian Blue-positive cells in the absence of Delta-Fc and signaling molecules, Alcian Blue-positive and nodule-like cell aggregates were found in almost all colonies in the presence of FGF2 (9/10) and Delta-Fc (7/7, Fig. 1D and E). To confirm whether or not Delta-Fc treatment causes the activation of Notch signaling, we examined the expression of Hairy enhancer of split1 (Hes1) at 24 h in culture. Hes1, which is a basic helix-loop-helix transcription factor, is a major downstream effector for Notch signaling (Artavanis-Tsakonas et al., 1999; Jarriault et al., 1995) . More intense immunoreactivity against anti-Hes1 was observed in the presence of Delta-Fc than in control cultures containing Fc only ( Fig. 1F and G) . The number of cells expressing Hes1 also increased by the addition of Delta-Fc (Fig. 1H) .
Furthermore, we performed immunocytochemistry using anti-collagen type II antibodies to detect proliferative and prehypertrophic chondrocytes (Nah et al., 1988) and counted the number of cells containing intracellular collagen type II at 10 days in culture to estimate the extent of chondrogenic differentiation. Cells expressing collagen type II were observed in the absence of Delta-Fc and signaling molecules ( Fig. 2A and E) , while the addition of FGF2 dramatically promoted the expression of collagen type II ( Fig. 2B and E) as reported in the experiments using quail mesencephalic neural crest cells (Sarkar et al., 2001 ). The treatment with FGF4 or FGF8 also stimulated collagen type II expression, but the effect of each was weaker than that of FGF2 (Fig. 2E) . When Delta-Fc was added to the cultures, the number of anti-collagen type II-positive cells increased significantly, similar to the case in FGF2 treatment ( Fig. 2C and E) . Anti-collagen type II-positive cells displayed a small and polygonal morphology and were first observed after 4 days in culture. These cells were found in and around cell aggregates reminiscent of cartilage nodules in the presence of FGF2 or Delta-Fc. In contrast, BMP treatment had no effect on the expression of collagen type II ( Fig. 2D and E) . However, the possibility can not be excluded that BMP activity in the culture medium containing serum and chick embryo extract (Abzhanov et al., 2003) affects chondrogenesis. Therefore, we used noggin, an antagonist of BMPs, to exclude this possibility. No significant changes of the number of anti-collagen type IIpositive cells were found in the presence of noggin (Fig. 2E) . The expression of collagen type II was promoted by Delta-Fc or FGF2 treatment in spite of the presence or absence of noggin (Fig. 2E) . Extracellular collagen type II was scarcely observed in the absence of Delta-Fc and signaling molecules or in the presence of BMPs on culture day 10, while the treatment with FGFs or Delta-Fc stimulated the expression of extracellular collagen type II.
BMPs and noggin had no effect on the chondrogenic differentiation of mouse mesencephalic neural crest cells. To confirm whether or not these signaling molecules work successfully in the culture conditions used in this study, we examined the differentiation of mouse trunk neural crest cells into autonomic neurons expressing mammalian achaete-scute homolog 1 (mash1), which is a marker of mammalian autonomic neurons and induced by BMP treatment (Reissmann et al., 1996; Shah et al., 1996; Lo et al., 2002) . When trunk neural cells were cultured in the same culture conditions as those employed in this study, a large number of anti-mash1-positive autonomic neurons were found in the presence of BMP4 (Fig. 2F and G) and this effect of BMP4 was dramatically suppressed by the addition of noggin (Fig. 2F) . Thus, BMPs and noggin function successfully in the present culture conditions. It has been known that FGFs or Notch signaling affects the neurogenesis of trunk neural crest cells (Murphy et al., 1994; Ota and Ito, 2006) . Therefore, we examined the effects of FGFs or Notch signaling on the neurogenesis of mouse mesencephalic neural crest cells. In contrast to chondrogenesis, neurogenic differentiation was inhibited by the addition of FGF2 or Delta-Fc ( Fig. 2H and I) .
Furthermore, we examined the expression of SOX9, a transcription activator of collagen type II (Bell et al., 1997) . SOX9 was first expressed on culture day 4, when anti-collagen type II-positive cells were first found. Anti-SOX9-positive cells expressed collagen type II, due to the activation of collagen type II expression by SOX 9 (Fig. 3A-C) . Whereas the expression of SOX9 was promoted by the treatment with Delta-Fc or FGF2, no significant increase of anti-SOX9-positive cells was observed in the presence of BMP4 (Fig. 3D) , as was also the case with collagen type II expression.
Critical Notch-sensitive period for chondrogenic differentiation
To establish whether or not there is a critical period during which Notch signaling is required for the differentiation of proliferative and prehypertrophic chondrocytes, mouse mesencephalic neural crest cells were exposed to Delta-Fc during several distinct periods of the cultures. The exposure to Delta-Fc for the first 24 h in culture was critical for the stimulation of collagen type II expression, while exposure during the periods 24-48 h and 48-72 h did not promote the expression of collagen type II (Fig. 4A) . Furthermore, the neural crest cells were transfected with the vector encoding the mouse Notch-1 intracellular domain (Notch-IC) during the first 24 h in culture. The overexpression of Notch-IC promoted the expression of collagen type II (Fig. 4A) . The most critical exposure period of FGF2 for collagen type II expression was also the first 24 h in culture (Fig. 4B) .
We examined the expression of p75, a low affinity neurotrophin receptor that is a marker for undifferentiated neural crest cells (Rao and Anderson, 1997) , at 24 h, 48 h, and 72 h in culture. When p75 expression was analyzed at 24 h in culture, epithelial components in primary explants were removed after the fixation and the emigrated neural crest cells on the substratum were stained with antip75. Whereas ninety-two percent (92.2 ± 1.51%) of total cells in a neural crest cell colony expressed p75 at 24 h, the percentage of anti-p75-positive cells rapidly decreased as culture time advanced ( Fig. 4C and D) . Thus, most of mouse mesencephalic neural crest cells expressed p75 at the critical culture period for the promotion of chondrogenic differentiation by Notch activation or FGF2 treatment.
Functional relationship between Notch signaling and FGF2
Since the effect of Notch activation on collagen type II expression was similar to that of FGF2, we analyzed the functional relationship between FGF2 and Notch signaling using Notch-1 siRNA to block the expression of Notch-1. The effect of Notch-1 siRNA was examined by immunostaining with anti-Notch-1. Anti-Notch-1-positive cells were observed in the absence of siRNA (Fig. 4E ) or in the presence of a negative control of Notch-1 siRNA (Fig. 4F) . Cells immunoreactive to anti-Notch-1 were hardly observed when Notch-1 siRNA was transfected ( Fig. 4G ), indicating that Notch-1 expression was efficiently inhibited by Notch-1 siR-NA treatment. When mouse mesencephalic neural crest cell cultures were treated with Notch-1 siRNA during the first 24 h in the presence of FGF2, the number of collagen type II-expressing cells significantly decreased (Fig. 4H ). This suppression of collagen type II expression by Notch-1 siRNA treatment was recovered by transfection with the expression vector encoding Notch-IC (Fig. 4H) . Moreover, the number of cells expressing collagen type II significantly decreased by the treatment with SU5402, which is a inhibitor of FGF signaling (Wang et al., 2006) , during the first 24 h in spite of the presence of FGF2. This suppression of collagen type II expression by SU5402 was recovered by the addition of Delta-Fc (Fig. 4H ).
Effects of Notch signaling and signaling molecules on cell proliferation
To examine the effects of Notch signaling and signaling molecules on growth of the neural crest cell colonies and on cell proliferation, enlargement of individual colonies was monitored by measuring colony diameter and a 5-bromo-2 0 -deoxyuridine (BrdU) incorporation was carried out Immunostaining with anti-collagen-type II was carried out on culture day 10. Delta-Fc was added at a concentration of 40 ll per ml of culture medium (1/25). FGF2 was applied at 10 ng/ml. Neural crest cells were exposed to Delta-Fc or FGF2 during the several distinct periods of the cultures. The vector encoding Notch-IC or the control vector were transfected for the first 24 h in culture. The asterisks indicate statistically significant differences from the number of anti-collagen type II-positive cells in the cultures exposed to Delta-Fc or FGF2 for 10 days (P < 0.05, t-test). Neural crest cells were exposed to 10 ng/ml FGF2 in the presence or absence of Notch-1 siRNA, the vector encoding Notch-IC, SU5402, Fc, and/or Delta-Fc during first 24 h in culture. Delta-Fc and Fc were added at a concentration of 40 ll per ml of culture medium (1/25). Immunostaining using anti-collagen type II was performed on culture day 10. The asterisks indicate statistically significant differences from the number of anti-collagen type II-positive cells in the presence of FGF2 only for the first 24 h (P < 0.05, t-test). Data are expressed as averages of separate counts of 3-13 colonies. Scale bars = 50lm. c using 10-day cultures. Colonies in cultures treated with Delta-Fc or FGFs exhibited more rapid growth than those in the absence of Delta-Fc and signaling molecules or in the presence of BMPs, noggin, or Fc only (Fig. 5A) . Furthermore, the percentage of BrdU-incorporated cells significantly increased by Notch activation or the treatment with FGFs (Fig. 5E ). The promotion of cell proliferation by FGF2 was suppressed by the treatment with Notch-1 siRNA (Fig. 5E ). When double-labeling experiments with anti-collagen type II and anti-BrdU were performed to explore the effects of Delta-Fc and signaling molecules on the proliferation of collagen type II-expressing cells, the double-labeled cells were observed on culture day 10 ( Fig. 5B-D ) but there were no significant differences with respect to the percentage of them under any of the conditions examined (Fig. 5F ).
Expression patterns of Notch-1, p75, and SOX9 in vivo
We investigated the expression patterns of Notch-1, p75, and SOX9 in the mandibular arch of the mouse embryo, where mesencephalic neural crest cells colonize and undergo chondrogenesis. At embryonic day (E) 8.5 (12-somite stage), anti-Notch-1 and anti-p75-positive cells were observed throughout the mandibular arch (Fig. 6B-D) . Intense immunoreactivity against anti-Notch-1 was found on the cell membrane, and the intracellular signal of Notch-1 was also observed (Fig. 6B) . Most of the anti-Notch-1-positive cells expressed p75 (Fig. 6D) . The expression of Notch-1 was lower at E9.5 (25-somite stage) than at E8.5 (Fig. 6E) . Furthermore, the expression of p75 also decreased dramatically from E8.5 to E9.5 (Fig. 6F) . A few cells expressing p75 were observed only in the dorsal portion of the mandibular arch. No anti-SOX9-positive cells were observed at E8.5 or E9.5. At E10.5 (39-somite stage), the expression level of Notch-1 was relatively low and anti-Notch-1-positive cells were found particularly in the surrounding of the mandibular arch (Fig. 6G) . Whereas the expression of p75 disappeared, a faint sign of SOX9 expression was seen in the central region. At E11.5 (46-somite stage), Notch-1-expressing cells were observed in the peripheral region of the mandibular arch (Fig. 6H) . Anti-SOX9-positive cells were localized in the central region, where Notch-1 was barely expressed (Fig. 6I-K) .
Using semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR), we examined the expression levels of Notch-1 in the mandibular arch at E8.5, E9.5, and . FGFs, BMPs, and noggin were used at 10-100 ng/ml. Colony size was assessed by measuring the diameter of the colonies using an eyepiece graticule with a linear scale fitted to an Olympus IMT microscope. The percentage increase in colony diameter was calculated using the following formula: (colony diameter at day x/colony diameter at day 2 after removing epithelial components in primary explants) ·100. E10.5. The advance of embryonic stages led to a decrease in Notch-1 expression (Fig. 6L) , supporting the immunohistochemical data described above.
Effects of Notch signaling and signaling molecules on the differentiation of hypertrophic chondrocytes
We examined the effects of Notch signaling and signaling molecules on the differentiation of mouse mesencephalic neural crest cells into hypertrophic chondrocytes. We immunocytochemically detected the expression of collagen type X, which is a marker of hypertrophic chondrocytes (Linsenmayer et al., 1991) . Anti-collagen type X-positive cells displayed a round morphology and were first found on culture day 10. The average number of hypertrophic chondrocytes per colony in the absence of Delta-Fc and signaling molecules were only forty (39.9 ± 10.8) on culture day 15. Because this cell number is not enough to analyze the effects of Delta-Fc and signaling molecules on the differentiation into hypertrophic chondrocytes, we added ascorbic acid to the medium to induce the expression of collagen type X (Fig. 7A , Leboy et al., 1989) . Whereas the treatment with FGF2 promoted, as described by Sarkar et al. (2001) , the differentiation of hypertrophic chondrocytes ( Fig. 7C and D) , Delta-Fc treatment significantly prevented collagen type X expression ( Fig. 7B and D) . The promotion of the differentiation into hypertrophic chondrocytes by FGF2 was significantly suppressed by Delta-Fc treatment (Fig. 7D) . BMP4 had no effect on the expression of collagen type X (Fig. 7D) . Since the critical Notch-and FGF-sensitive periods for the differentiation of anti-collagen type II-positive proliferative and prehypertrophic chondrocytes were the first 24 h in culture, we investigated the effects of the exposure to Delta-Fc or FGF2 during the first 24 h on collagen type X expression. The expression of collagen type X remained unchanged in treatment with Delta-Fc or FGF2 for the first 24 h only (Fig. 7E ).
Discussion
Notch activation promotes the differentiation of mouse mesencephalic neural crest cells into proliferative and prehypertrophic chondrocytes
We demonstrated that the activation of Notch signaling by the addition of Delta-Fc stimulates the expression of collagen type II. This result suggests that Notch activation positively regulates the differentiation of mouse mesencephalic neural crest cells into proliferative and prehypertrophic chondrocytes. FGF2 is known to promote the chondrogenic differentiation of quail mesencephalic neural crest cells (Sarkar et al., 2001 ). This signaling molecule also promotes the chondrogenic differentiation of mouse mesencephalic neural crest cells. Furthermore, the present study indicated that FGF4 and FGF8 can stimulate chondrogenesis in the mouse. It has been reported that FGF8 induces the expression of FGF2 (Kubota and Ito, 2000) . Therefore, FGF8 may affect chondrogenesis through the induction of FGF2. Notch activation and FGF2 treatment also promoted the expression of SOX9. This result indicates that the promotion of SOX9 expression by Notch activation or FGF2 treatment leads to the differentiation of proliferative and prehypertrophic chondrocytes.
Notch activation promotes the gliogenesis of trunk neural crest cells (Morrison et al., 2000; Ota and Ito, 2006) . It has been shown that trunk neural crest cells differ from the cranial neural crest cells in how they respond to specific extracellular signals (Abzhanov et al., 2003) . Notch signaling may participate in the chondrogenesis in cranial (mesencephalic) neural crest development and in the gliogenesis in the differentiation of trunk neural crest cells. Furthermore, different populations of mesencephalic neural crest cells may exhibit differential competence to respond to extracellular signals. It is conceivable that chondrogenic differentiation Fig. 7 . Differentiation of hypertrophic chondrocytes expressing collagen type X in mouse mesencephalic neural crest cell cultures. Immunostaining using anti-collagen type X was carried out on culture day 15. Delta-Fc and Fc were added at a concentration of 40 ll per ml of culture medium (1/25). FGF2 and BMP4 were applied at 10 ng/ml. Ascorbic acid was added at 50 lg/ml. (A-C) Anti-collagen type X-positive cells under the various conditions examined. (D) The number of cells expressing collagen type X per neural crest cell colony. Neural crest cells were exposed to Delta-Fc, Fc, FGF2, and/or BMP4 in the presence of ascorbic acid during 15 days. The asterisks indicate statistically significant differences from the number of anti-collagen type Xpositive cells in the presence of ascorbic acid only (P < 0.05, t-test). (E) The number of cells expressing collagen type X per colony in the neural crest cell cultures that were treated with Delta-Fc, Fc, or FGF2 for the first 24 h only. Ascorbic acid was present during the whole culture period. The data are expressed as the average of separate counts of 6-11 colonies. Scale bar = 50 lm.
is promoted by Notch activation in a particular population of mesencephalic neural crest cells but, in a different population of them, another differentiation pathway, such as glial differentiation, is activated by the same signal.
BMPs had no effect on collagen type II or SOX9 expression. BMP signaling is shown to promote chondrogenesis of limb bud mesenchymal cells Chen et al., 1991; Duprez et al., 1996; Kobayashi et al., 2005) , mandibular arch mesenchyme (Langille, 1994) , and established cell lines (Ahrens et al., 1993; Wang et al., 1993) . On the other hand, Ekanayake and Hall (1997) and Abzhanov et al. (2003) revealed that BMPs suppress the chondrogenic differentiation of chick and quail cranial neural crest cells. This discrepancy in the effects of BMPs on chondrogenesis remains unknown. Semba et al. (2000) indicated that BMPs induce chondrogenesis of mandibular arch mesenchyme in a positionally dependent manner. The effects of BMPs on chondrogenesis may differ, depending on the developmental state and/or embryonic position of cells that undergo chondrogenesis. Sarkar et al. (2001) showed that exposure to FGF2 during only the first 24 h in culture is necessary but not sufficient to drive the chondrogenesis of quail mesencephalic neural crest cells. The present data demonstrate that Notch activation or FGF2 treatment during the first 24-h period is sufficient to promote the differentiation of mouse mesencephalic neural crest cells into proliferative and prehypertrophic chondrocytes. They expressed both Notch-1 and p75 at 24 h in culture. These results suggest that Notch signaling and FGF2 act at the early stages of the chondrogenesis of the mesencephalic neural crest cells. Thus, it is conceivable that Notch signaling and FGF2 may be responsible for the specification of chondrocytes. FGF2 is shown to stimulate the expression of Notch-1 (Ota and Ito, 2006) . Furthermore, when the activation of Notch signaling was inhibited by Notch-1 siRNA in the presence of FGF2, the promotion of chondrogenic differentiation by FGF2 was suppressed. Notch activation by Delta-Fc sufficiently promoted chondrogenic differentiation even when FGF signaling was inhibited by SU5402. These data suggest that FGFs activate Notch signaling and that this activation affects the specification of mouse mesencephalic neural crest cells to chondrocytes.
FGFs may participate in the specification of chondrocytes by means of Notch activation
Although colony growth and cell proliferation were stimulated by Notch activation or FGF treatment, no significant differences were found with respect to the proportion of collagen type II-expressing cells labeled with BrdU. Therefore, the increase in the number of collagen type IIexpressing cells may be due to the promotion of proliferative and prehypertrophic chondrocyte differentiation by FGF treatment or Notch activation. This result also supports the notion that FGF treatment and Notch activation participate in the specification of mouse mesencephalic neural crest cells to chondrocytes.
There were no statistically significant differences in the size of neural crest colonies (average size = 1375.0 ± 22.5 lm) at 24 h in culture, that is the critical culture period for chondrogenic specification by Notch activation and FGF2 treatment, under any of the conditions examined. In the nuclear-staining experiments using 4 0 6-diamidino-2-phenylindole (DAPI), cell death was scarcely observed in all culture conditions examined during the first 24 h. These observations suggest that the extent of cell survival and death during 24 h in culture does not change among the present culture conditions, and thus are not likely to support the possibility that Notch activation and FGF treatment at the critical period for chondrogenic specification selectively promote the survival of chondrocyte precursors, although this possibility is not excluded completely.
3.3. Notch signaling may be a component of epithelialmesenchymal interactions that play important roles in the specification of chondrocytes Epithelial-mesenchymal interactions are known to be required for the promotion of chondrogenesis of cranial neural crest cells in vivo (Bee and Thorogood, 1980; Thorogood, 1993; Hall, 1999) . It has been suggested that FGFs are components of such interactions (Frenz et al., 1994; Sarkar et al., 2001; Walshe and Mason, 2003) . Furthermore, we demonstrated that Notch signaling mediates the actions of FGF2 that stimulate the chondrogenesis of mouse mesencephalic neural crest cells. Thus, it is possible that Notch signaling plays an important role in the epithelial-mesenchymal interactions.
In the mouse, epithelial-mesenchymal interactions that promote chondrogenesis in the mandibular arch occur after neural crest cells reach the arch (Hall, 1987) . Since the arrival of mouse cranial neural crest cells at the mandibular arch is completed by E8.5-9.0 (Serbedzija et al., 1992) , such interactions may start by E8.5-9.0. We suggested that FGFs affect the specification of chondrocytes through Notch activation in the culture period (first 24 h in culture) when the mesencephalic neural crest cells still express p75. Furthermore, the intense signals of Notch-1 and p75 were observed in the E8.5 mandibular arch. These data suggest that the developmental state of the mesencephalic neural crest cells that undergo the specification of chondrocytes by FGFs and Notch signaling is equivalent to the state of E8.5 mandibular arch mesenchymal cells. Thus, in the mouse, epithelial-mesenchymal interactions that are mediated by FGFs and Notch signaling may occur around E8.5 and participate in the specification of the mesencephalic neural crest cells to chondrocytes.
SOX9 expression began after 4 days in culture. Since the specification of mouse mesencephalic neural crest cells to chondrocytes may occur during the first 24 h in culture, neither FGFs nor Notch signaling is likely to induce the expression of SOX9 directly. Indeed, epithelial-mesenchymal interactions that are mediated by FGFs and Notch signaling may occur around E8.5, while the expression of SOX9 was observed in the central region of the mandibular arch, in which Notch-1 expression was downregulated, after E10.5. It has been reported that SOX9 is required for the determination of chondrocytes (Mori-Akiyama et al., 2003) . However, the present data suggest that epithelial-mesenchymal interactions before the expression of SOX9, which are mediated by FGFs and Notch signaling, are also indispensable for the determination of chondrocytes in the mouse mandibular arch. The chondrogenic determination in the mandibular arch may be initiated by the epithelial-mesenchymal interactions and completed by SOX9 expression.
Notch activation suppresses the maturation from proliferative and prehypertrophic chondrocytes to hypertrophic chondrocytes
It has been reported that the activation of Notch signaling suppresses chondrogenesis (Watanabe et al., 2003) , particularly the transition from prehypertrophic chondrocytes to hypertrophic chondrocytes in the chick limb bud (Crowe et al., 1999) . Therefore, we investigated the roles of Notch signaling in the differentiation of mouse mesencephalic neural crest cells into hypertrophic chondrocytes. Whereas FGF2 promoted the differentiation of hypertrophic chondrocytes, Notch activation prevented it. The promotion of the differentiation of hypertrophic chondrocytes by FGF2 was prevented by Delta-Fc treatment. Moreover, neither exposure to Delta-Fc nor exposure to FGF2 for the first 24 h in culture affected the maturation to hypertrophic chondrocytes. Thus, the specification of chondrocytes may be promoted by FGF treatment and Notch activation, while the maturation from proliferative and prehypertrophic chondrocytes to hypertrophic chondrocytes may be stimulated by FGFs but suppressed by Notch signaling. Notch signaling may carry out opposite functions in different phases of the chondrogenesis of mouse mesencephalic neural crest cells. In contrast, BMP4 had no effects on the transition to hypertrophic chondrocytes. BMPs may be irrelevant to the chondrogenesis of mouse mesencephalic neural crest cells.
Experimental procedures
Primary cultures
Primary cultures of mesencephalic neural crest cells were prepared from E8.0 (6-to 8-somite stages) ddY mouse embryos (Ito and Morita, 1995; Kubota and Ito, 2000; Ota and Ito, 2003) . Neural folds at mesencephalic levels were dissected and cut into fragments. These fragments were explanted in 35-mm culture dishes coated with collagen gel (Celtrix). Epithelial components in primary explants were scraped away with a tungsten needle after 48 h, leaving the emigrated mesencephalic neural crest cells on the substratum. Primary cultures of trunk neural crest cells were prepared from E9.5 (21-to 29-somite stages) ddY mouse embryos (Ito et al., 1993) . The dorsal trunk region was dissected at the last six somite levels. Neural tubes were isolated by trypsinization and explanted into 35-mm collagen-coated culture dishes. Twenty-four hours later, the neural tubes in the primary explants were scraped away with a tungsten needle, leaving the emigrated trunk neural crest cells on the substratum. The culture medium consisted of 85% a-modified minimum essential medium (a-MEM, Sigma), 10% fetal bovine serum (FBS, Hyclone), 5% extract of day 11 chick embryos, and 50 lg/ml gentamicin (Sigma). The cultures were incubated at 37°C in a humidified atmosphere containing 5% CO 2 . The culture medium was changed every other day. FGF2, FGF4, and FGF8 (R&D Systems) were each added to the medium at a concentration of 10 ng/ml. BMP2 (R&D Systems), BMP4 (a gift from the Genetics Institute), and BMP7 (R&D Systems) were applied at 10-100 ng/ml. Noggin (R&D Systems), ascorbic acid (Wako) and SU5402 (Calbiochem) were used at 100 ng/ml, 50 lg/ml, and 5 lM, respectively.
Treatment with Delta-Fc
The preparation of Delta-Fc and Fc was described previously (Ota and Ito, 2006) . Using the liposome method (TransIT-LT1, Takara), 0.8 lg of the pSMT expression vector encoding the extracellular domain of mouse Delta-1 and Fc (a gift from Dr. H. Hirai, Shimizu et al., 1999 Shimizu et al., , 2000 or 2 lg of the control vector encoding Fc only was transfected into COS7 cells. The transfected COS7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) with 10% FBS. When the cultures became confluent, the medium was replaced with DMEM without FBS. After 5 days of incubation, the supernatant containing Delta-Fc or Fc was harvested from the cultures. The Delta-Fc-or Fc-conditioned medium was concentrated by centrifugation in an Amicon Ultra-15 centrifugal filter device (Millipore) to achieve a 50-fold total net concentration. The concentrated supernatant was added to the neural crest cell cultures at a concentration of 40 ll per ml of culture medium (Morrison et al., 2000; Faux et al., 2001; Ota and Ito, 2006) .
Transfection of the vector encoding Notch-IC
To obtain mouse mesencephalic neural crest cells that overexpress Notch-IC, mesencephalic neural crest cells were transfected with 2 lg of the pcDNA3 expression vector encoding Notch-IC and a myc epitope (a gift from Dr. J.S. Nye, Nye et al., 1994; Foltz et al., 2002 ) using Lipofectamine 2000 for the first 24 h in culture. The transfection efficiency of the vector was estimated by immunostaining with mouse anti-c-myc (9E10) (1:100, Santa Cruz) as described previously (Ota and Ito, 2006) . The percentage of cells expressing the myc epitope per neural crest cell colony reached 66.1 (±6.7)%. As a control experiment, transfection of the pcDNA3 vector encoding the myc epitope only (control vector) was carried out under the same conditions as those used for the Notch-IC transfection. 
siRNA preparation
RT-PCR
RT-PCR was performed by using mandibular arches of E8.5, E9.5, and E10.5 ddY mouse embryos. The total RNA was purified with the RNeasy Mini Kit (Qiagen). Reverse transcription of mRNA from the total RNA followed the manufacturer's instructions for Superscript II (GibcoBRL). The cDNA was amplified with specific primer sets and Taq polymerase (Takara) in a thermal cycler (Takara) using the following program: 94°C for 60 s; 55°C for 30 s; 72°C for 30 s. Aliquots (8 ll) of the PCR products were separated on 2% agarose gel (Nippon Gene) and were stained with ethidium bromide. The cDNA content was adjusted according to the staining intensity of standard b-actin PCR products. Cycle numbers were determined to be in the linear range for Notch-1 and b-actin. The following primer sets were used: a Notch-1 primer set, 5 0 primer 5 0 -TTA CAGCCACCATCACAGCCACACC-3 0 and 3 0 primer 5 0 -ATGCCCTC GGACCAATCAGA-3 0 , which amplifies a 380-bp fragment (Faux et al., 2001) ; and a b-actin primer set, 5 0 primer 5 0 -GTGGGCCGCTCTAGGC ACCAA-3 0 and 3 0 primer 5 0 -CTCTTTGATGTCACGCACGATTTC-3 0 , which amplifies a 540-bp fragment (Alonso et al., 1986 ).
Histological detection of chondrocytes
Chondrocytes in mouse mesencephalic neural crest cell cultures were detected by Alcian Blue staining with modifications of the method developed by Simons and van Horn (1971) as described previously (Ido and Ito, 2006) . The cultures were treated with a solution containing 7.8 mg Alcian Blue in 40 ml ethanol and 10 ml acetic acid at room temperature for 96 h. The cultures were then dehydrated with ethanol for 24 h. Finally, the cultures were covered with glycerol.
Immunostaining
Primary cultures of mouse neural crest cells were fixed with 4% paraformaldehyde (PFA) for 1 h on ice or with 10% formalin for 10 min at 4°C. The cultures were immunostained with the following primary antibodies: (1) goat anti-collagen type II (1:50, Southern Biotechnology), (2) rabbit anti-SOX9 (1:100, Santa Cruz), (3) rabbit anti-collagen type X (1:500, LSL), (4) goat anti-Notch-1 (1:100, Santa Cruz), (5) rabbit antip75 (1:100, Promega), (6) rabbit anti-Hes1 (1:1000, a gift from Dr. T. Sudo, Ito et al., 2000) , (7) mouse anti-mash1 (1:5, a gift from Dr. D.J. Anderson, Lo et al., 1991) , and (8) mouse anti-neurofilament 68 kDa (1:4, Boehringer). Embryos were fixed with 4% PFA for 1-2 h on ice. Fixed embryos were immersed in gradually increasing sucrose solution and embedded in OCT compound (Miles). Cryostat sections were cut at 10 lm and mounted on albumin-coated glass slides. The sections were stained using the following primary antibodies: (1) rabbit anti-SOX9 (1:100), (2) goat anti-Notch-1 (1:200), and (3) rabbit anti-p75 (1:100). Primary antibodies were applied for 12 h at 4°C. The specimens were treated with the following secondary antibodies at room temperature for 1 h: (1) fluorescein isothiocyanate (FITC)-conjugated donkey anti-goat IgG (1:50, Chemicon), (2) rhodamine-conjugated donkey anti-goat IgG (1:50, Chemicon), (3) FITC-conjugated donkey anti-rabbit IgG (1:50, Chemicon), (4) Alexa-488-conjugated goat anti-rabbit IgG (1:500, Molecular Probes), and (5) Alexa-488-conjugated goat anti-mouse IgG (1:500, Molecular Probes). Finally, the specimens were nuclear-stained with 0.1 lg/ml DAPI (Dojindo). DAPI-nuclear staining was particularly important for counting the exact number of immunoreactive cells, such as cells expressing intracellular collagen type II, in the neural crest cell cultures.
BrdU incorporation
BrdU-labeling experiments were performed to estimate proliferation in mouse mesencephalic neural crest cell cultures. BrdU (Wako) was prepared as a 1 mM stock solution in a-MEM and was added to the cultures at a final concentration of 50 lM. The cultures were exposed to BrdU for 90 min and were subsequently fixed in 4% PFA on ice for 1 h. BrdU-incorporated cells were detected with mouse monoclonal anti-BrdU antibodies (1:10, Becton-Dickinson). In double-stainings with anti-collagen type II and anti-BrdU, FITC-conjugated donkey anti-goat IgG and rhodamineconjugated donkey anti-mouse IgG (1:50, Chemicon) were used as secondary antibodies. The cultures were nuclear-stained with 0.1 lg/ml DAPI for the total cell count.
